The Medical Industry Briefing 

The latest news, approvals and clinical trials you need to know about this month

Data: News
in Numbers


Royal Philips has announced the one millionth procedure on its flagship Azurion image-guided therapy platform.

$5.2 billion

The estimated value of India’s medical device industry.

£3.43 billion

The smart biopsy devices market is expected to generate revenue of around $3.43bn by end of 2025 according to Zion Market Research.


According to research from the ICIJ, of the 340,000 injury and death cases reported as part of the US FDA’s implant scandal, approximately 67% were female.


The number of applications chosen by the FDA as part of its Innovation Challenges scheme to improve sterilisation processes.

 Top Stories 

 Roche launches mobile lab management app

Roche has announced the launch of the cobas mobile solution, a tablet app that allows laboratory personnel to be better connected with each other and their work. Designed to enable faster decision-making and enhance walkaway times, cobas allows laboratory workers to interact directly with their analysers from anywhere in the lab.

Source: Medical Device Network

  Device tester launches European operations in France

Medical Engineering Technologies’ (MET) medical and combination device test house has launched its European operations in France. The new laboratories are specifically designed to provide batch release testing for pharmaceutical delivery devices.

Source: Med Tech News

 Toyota helps more patients to walk

Toyota Motor Corporation has unveiled its new Welwalk WW-2000, a robot designed to provide rehabilitation support to individuals with lower limb paralysis as a result of stroke and other causes.

Source: Toyota

 Baring Private Equity Asia to buy medical device maker Lumenis

Baring Private Equity Asia has agreed to acquire Lumenis from London-based investment firm XIO Group in a deal that values the Israeli medical device maker at more than $1 billion.

Source: Reuters

Embracing Emerging Technologies 


The Cambridge-based startup uses AI, machine learning and pharmacological expertise to accelerate the discovery and development of treatments at scale.


London-based medtech startup FundamentalVR has created a virtual reality (VR) training and data analysis technology platform.


An AI-native digital pathology ecosystem that augments the Pathologist, accelerates new biomarker discovery, and is built for new insight generation.


Currently in development this device is a high tech nanosensor that is placed on the tooth which detects glucose level in the saliva and transfers information to an external app.

Share this article